TAT 2015: Cutting edge research and unique interaction between academia and industry
TAT 2015: Cutting edge research and unique interaction between academia and industry
Meeting highlights from the 12th iwNHL 2014: Day 1
Meeting highlights from the 12th iwNHL 2014: Day 2
ESMO 2014 Editor's roundup
Prognostic biomarkers will detect lung cancer at earlier stages
vandetanib improves PFS in thyroid cancer
E-hospital: Fully coordinated cancer care and research in Europe
ESMO Highlights: Breast cancer
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma
Nivolumab potentially superior to standard chemo in advanced melanoma
Targeted therapy for iodine-refractory thyroid cancer
Young oncologists bridging the gap between translational and clinical cancer research